The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Home > Documents > Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for receival of shares from the capital increase of Sopharma AD
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for receival of shares from the capital increase of Sopharma AD